Working Up Policy: The Use of Specific Disease Exemplars in Formulating General Principles Governing Childhood Genetic Testing [Book Review]
Health Care Analysis 14 (1):1-13 (2006)
|Abstract||Non-therapeutic genetic testing in childhood presents a “myriad of ethical questions”; questions which are discussed and resolved in professional policy and position statements. In this paper we consider an underdiscussed but strongly influential feature of policy-making, the role of selective case and exemplar in the production of general recommendations. Our analysis, in the tradition of rhetoric and argumentation, examines the predominate use of three particular disease exemplar (Huntington’s disease, Tay-Sachs disease and sickle cell disease) to argue for or against particular genetic tests (predictive testing and testing for carrier status). We discuss the influence these choices have on the type and strength of subsequent recommendations. We argue that there are lessons to be drawn about how genetic diseases are conceptualised and we caution against the geneticisation of medical policy making|
|Keywords||Genetic testing Geneticisation Huntington’s disease Policy-making Tay Sachs’ disease Sickle cell disease Stigma|
|Categories||categorize this paper)|
|Through your library||Configure|
Similar books and articles
Lainie Friedman Ross (2002). Predictive Genetic Testing for Conditions That Present in Childhood. Kennedy Institute of Ethics Journal 12 (3):225-244.
Mariam Ghosn (2007). Predictive Testing for Huntington's Disease in Adolescents: Part 2. Chisholm Health Ethics Bulletin 12 (3):3.
Barabara Biesecker (1998). Future Directions in Genetic Counseling: Practical and Ethical Considerations. Kennedy Institute of Ethics Journal 8 (2):145-160.
Susan Lindee & Rebecca Mueller (2011). Is Cystic Fibrosis Genetic Medicine's Canary? Perspectives in Biology and Medicine 54 (3):316-331.
Robert Samuel Wachbroit (1998). The Question Not Asked: The Challenge of Pleiotropic Genetic Tests. Kennedy Institute of Ethics Journal 8 (2):131-144.
Claudia Wild (2007). Polymorphism-Screening: Genetic Testing for Predisposition—Guidance for Technology Assessment. [REVIEW] Poiesis and Praxis 5 (1):1-14.
Lisa Bortolotti & Heather Widdows (2011). The Right Not to Know: The Case of Psychiatric Disorders. Journal of Medical Ethics 37 (11):673-676.
Jeffrey P. Kahn & Anna C. Mastroianni (2004). Creating a Stem Cell Donor: A Case Study in Reproductive Genetics. Kennedy Institute of Ethics Journal 14 (1):81-96.
Kathryn Edge (2013). The Benefits and Potential Harms of Genetic Testing for Huntington's Disease: A Case Study. Human Reproduction and Genetic Ethics 14 (2):14 - 19.
Inmaculada de Melo-Martín (2006). Genetic Testing: The Appropriate Means for a Desired Goal? [REVIEW] Journal of Bioethical Inquiry 3 (3):167-177.
Sean A. Valles (2010). The Mystery of the Mystery of Common Genetic Diseases. Biology and Philosophy 25 (2):183-201.
Loretta M. Kopelman (2007). Using the Best Interests Standard to Decide Whether to Test Children for Untreatable, Late-Onset Genetic Diseases. Journal of Medicine and Philosophy 32 (4):375 – 394.
P. Lilja Andersson, N. Juth, A. Petersen, C. Graff & A. -K. Edberg (forthcoming). Ethical Aspects of Undergoing a Predictive Genetic Testing for Huntington's Disease. Nursing Ethics 20 (2):0969733012452686.
Cheryl Berg & Kelly Fryer-Edwards (2008). The Ethical Challenges of Direct-to-Consumer Genetic Testing. Journal of Business Ethics 77 (1):17 - 31.
Sorry, there are not enough data points to plot this chart.
Added to index2011-01-29
Total downloads1 ( #291,948 of 722,929 )
Recent downloads (6 months)1 ( #61,087 of 722,929 )
How can I increase my downloads?